信州大学HOMEENGLISH交通・キャンパス案内

研究者総覧研究者総覧

研究者、研究内容などで検索
項目別検索はこちら

田中 榮司  タナカ エイジ

教員組織電話番号0263-37-2634
教育組織医学部 医学科 地域医療推進学FAX番号0263-32-9412
職名特任教授メールアドレス
住所〒390-8621 松本市旭3-1-1ホームページURLhttp://www.shinshu-u.ac.jp/faculty/medicine/chair/i-2nai/

更新日:2020/10/26

プロフィール

兼担研究科・学部
医学部附属病院 内科(2)
研究分野
消化器内科学
現在の研究課題
B型肝炎の抗ウイルス療法
キーワード:B型肝炎ウイルス , インターフェロン , 核酸アナログ薬
B型肝炎の再活性化
キーワード:de novo B型肝炎
C型肝炎の抗ウイルス療法
キーワード:C型肝炎ウイルス , インターフェロン , DAAs
自己免疫性肝疾患の遺伝的背景
キーワード:自己免疫性肝炎 , 原発性胆汁性肝硬変
脂肪性肝疾患の診断と治療
キーワード:NASH
重症肝疾患の肝移植

所属学会
所属学会
日本癌学会
日本ウイルス学会
米国肝臓学会
日本消化器内視鏡学会

所属学会役職担当
日本内科学会 , 評議員
日本消化器病学会 , 財団評議員
日本肝臓学会 , 理事
学歴
出身大学院
1982 , 信州大学 , 医学研究科

出身学校・専攻等(大学院を除く)
1978 , 金沢大学 , 医学部

取得学位
博士(医学) , 信州大学
研究職歴等
研究職歴
2008- , 信州大学(医学部) 教授
2007-2008 , 信州大学(医学部) 准教授
2001-2007 , 信州大学(医学部) 助教授
1995-2001 , 信州大学(医学部) 講師
1988-1995 , 信州大学(医学部) 助手

研究活動業績

研究業績(著書・
発表論文等)
著書
B型肝炎のおはなし
シスメックス株式会社 , :1-14 2019
Author:田中榮司


C型肝炎のおはなし
シスメックス株式会社 , :1-14 2019
Author:田中榮司


長野県における肝硬変の成因実態
医学図書出版, 東京 , 日本肝臓学会(監修), 西口修平(監修), 上野義之, 日浅陽一, 榎本平之(編):肝硬変の成因別実態 , :80-81 2019
Author:杉浦亜弓, 城下智, 髙橋芳之, 栗林直矢, 山崎智生, 藤森尚之, 梅村武司, 松本晶博, 田中榮司


B型慢性肝炎の予後(治療による発癌抑止)
最新医学社,大阪 , 編:ウィルス性肝炎 消化器3 , :pp 171-176 2005
Author:松本晶博,田中榮司,清澤研道


B型慢性肝炎に対するラミブジン治療調査報告
アークメディア,東京 , 犬山シンポジウム記録刊行会編:ウイルス肝炎からの発癌とその予防 , :pp 159-165 2005
Author:清澤研道,松本晶博,田中榮司,犬山肝炎研究グループ


急性肝炎の診断と治療(各論)(5)その他のウィルス性急性肝炎
最新医学社,大阪 , 林紀夫編:ウィルス性肝炎 消化器3 , :pp 106-114 2005
Author:田中栄司


Ⅲ肝・胆道機能検査
金原出版,東京 , 金井正光編:臨床検査法提要第32版 , :pp 1335-1387 2005
Author:田中栄司


C型肝炎の治療
医薬ジャーナル社,東京 , 清澤研道編:ナースのための肝炎看護ハンドブック C型肝炎対策を中心に , :pp 42-53 2004
Author:田中栄司


C型肝炎の検査法
医薬ジャーナル社,東京 , 清澤研道編:ナースのための肝炎看護ハンドブック C型肝炎対策を中心に , :pp 33-41 2004
Author:田中栄司


C型慢性肝炎の治療とウイルスマーカー
先端医学社,東京 , 林 紀夫,岡上 武,熊田博光編:C型慢性肝炎治療の新たなストラテジー(インターフェロン治療の今後) , :pp 51-57 2004
Author:田中栄司


C型肝炎治療の総論
アークメディア,東京 , 各務伸一編:コンセンサス2004肝疾患治療 , :pp 77-83 2004
Author:田中栄司


術後肝障害の対策
医学書院,東京 , 二ノ宮節夫,冨士川恭輔,越知隆弘,国分正一,岩谷力編:今日の整形外科治療指針第5版 , :pp 32-32 2004
Author:田中栄司


肝臓の病気/肝炎 C型急性肝炎 C型慢性肝炎 B型漫性肝炎
法研,東京 , 高久史麿,猿田亨男,北村惣一郎,福井次矢編:家庭医学大全科 , :pp 2023-2029 2004
Author:田中栄司


慢性肝炎の治療と肝炎ウイルスマーカー
総合医学社,東京 , 石橋大海編:今月の治療 , :pp 1105-1108 2003
Author:田中榮司


グローバル時代の感染症学 ウイルス感染症 ウイルス性肝炎 E型肝炎
日本臨床社,東京 , 山口惠三,岩本愛吉編:日本臨床 , :pp 249-253 2003
Author:田中榮司


ウイルス性肝炎の現況 SENウイルスとその臨床的意義
医歯薬出版,東京 , 熊田博光編:医学のあゆみ , :pp 31-34 2003
Author:田中榮司


Lamivudine 治療はB型肝炎の自然経過を修飾するか
アークメディア,東京 , 犬山シンポジウム記録刊行会編:B型・C型肝炎の病態と治療(第24回犬山シンポジウム) , :pp 3-9 2003
Author:清澤研道,田中榮司,松本晶博,熊田博光,小俣正男


新しいHBV定量系HBVコア関連抗原(HBcrAg)の臨床的応用性.犬山シンポジウム記録刊行会編:B型・C型肝炎治療の新たな展開
アークメディア , :pp 15-19 2002
Author:六波羅明紀,田中榮司,松本晶博,木村達治,八木慎太郎,槇昇,清澤研道


C型肝硬変の生体肝移植.熊田博光編:C型慢性肝炎の治療最前線ー最近の知見と治療ー
メディカルレビュー社 , :pp 222-227 2002
Author:田中榮司


C型肝炎,自然経過と予後.矢野右人,林紀夫,沖田極編:コンセンサス肝疾患2002診断・治療と病態
日本メディカルセンター , :pp 114-123 2002
Author:田中榮司


Hepatocellular carcinoma and Hepatitis C. Sarin SK. Okuda K: Hepatitis B and C carrier to cancer
ELSEVIER INDIA , :pp 315-329 2002
Author:Kiyosawa K, Tanaka E


Hepatitis C virus in the etiology of hepatocellular carcinoma. Tabor E: Virus and Liver Cancer
ELSEVIER , :pp 31-42 2002
Author:Kiyosawa K, Tanaka E


論文
胆嚢癌との鑑別が困難な画像所見を呈した胆嚢線維性ポリープの1例
胆道,33(5):854-861 2019(Dec.)
Author:芦原典宏, 渡邉貴之, 倉石康弘, 小澤真希子, 中村晃, 金井圭太, 大月聡明, 浜野英明, 田中榮司


Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
J Gastroenterol Hepatol 2019(Nov.)
Author:Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T


Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma
Pathol Res Pract,215(11):152623 2019(Nov.)
Author:Kuraishi Y, Uehara T, Kobayashi Y, Nakajima T, Watanabe T, Shimizu A, Ota H, Tanaka E:


KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
JHEP Rep,1(5):353-360 2019(Nov.)
Author:Umemura T, Joshita S, Saito H, Yoshizawa K, Norman GL, Tanaka E, Ota M


嚢胞周囲に限局した自己免疫性膵炎の1例
膵臓,34(5):239-246 2019(Oct.)
Author:小澤真希子, 渡邉貴之, 芦原典宏, 倉石康弘, 中村晃, 金井圭太, 松本有機, 小林実喜子, 田中榮司


Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
Hepatol Res,49(10):1236-1243 2019(Oct.)
Author:Joshita S, Umemura T, Yamashita Y, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E


Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society
Hepatol Res,49(9):964-980 2019(Sep.)
Author:Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H


Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
Medicine (Baltimore),98(30):e16619 2019(Jul.)
Author:Kobayashi S, Joshita S, Yamamoto C, Yanagisawa T, Miyazawa T, Miyazawa M, Kubota D, Sato J, Umemura T, Tanaka E


What will happen in patients with advanced nonalcoholic fatty liver
Hepatobiliary Surg Nutr,8(3):283-285 2019(Jun.)
Author:Kimura T, Tanaka N, Tanaka E


【肝臓病学の未来-ウイルス性肝炎から脂肪肝と肝がんの時代へ】NAFLD/NASH 期待される新薬
内科,123(5):1155-1158 2019(May)
Author:田中直樹, 木村岳史, 藤森尚之, 田中榮司


Response to the letter by Matsushita et al. regarding our manuscript "Resection Depth and Layer of Cold Snare Polypectomy versus Endoscopic Mucosal Resection"
J Gastroenterol,54(5):473 2019(May)
Author:Suga T, Ito A, Ota H, Tateiwa N, Matsumoto A, Tanaka E


Red plasma and ascites under ultraviolet A
Lancet Gastroenterol Hepatol,4(4):324 2019(Apr.)
Author:Wakabayashi SI, Kimura T, Tanaka N, Komatsu M, Tanaka E


A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
Case Rep Oncol Med,:8357893 2019(Mar.)
Author:Kako S, Joshita S, Matsuo A, Kawaguchi K, Umemura T, Tanaka E


ウイルス肝炎と歩んだ40年
信州医学雑誌,67(1):27-30 2019(Feb.)
Author:田中榮司


【消化器癌の危険因子・予防対策】 肝臓癌のリスクファクターと予防対策 肝炎ウイルス以外
消化器・肝臓内科,5(2):215-221 2019(Feb.)
Author:田中直樹, 木村岳史, 藤森尚之, 田中榮司


Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
Medicine (Baltimore),98(6):e14475 2019(Feb.)
Author:Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E


Current status, problems, and perspectives of non-alcoholic fatty liver disease research
World J Gastroenterol,25(2):163-177 2019(Jan.)
Author:Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E


Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals
J Viral Hepat,25(12):1462-1471 2018(Dec.)
Author:Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E


Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
Hepatol Res,48(13):1092-1098 2018(Dec.)
Author:Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E


Resection depth and layer of cold snare polypectomy versus endoscopic mucosal resection
J Gastroenterol,53(11):1171-1178 2018(Nov.)
Author:Ito A, Suga T, Ota H, Tateiwa N, Matsumoto A, Tanaka E


Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
Cytokine,111:357-363 2018(Oct.)
Author:Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E


A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
Sci Rep,8(1):11924 2018(Aug.)
Author:Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M


Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma
Clin J Gastroenterol,11(4):302-308 2018(Aug.)
Author:Wakabayashi SI, Kimura T, Tanaka N, Joshita S, Kawata K, Umemura T, Hiroshima Y, Mori H, Kobayashi H, Wada S, Tanaka E


Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori
Clin Endosc,51(4):362-367 2018(Jul.)
Author:Okamura T, Iwaya Y, Kitahara K, Suga T, Tanaka E


Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature
Ann Hepatol,17(4):655-660 2018(Jul.)
Author:Fujii F, Kimura T, Tanaka N, Kubota D, Sugiura A, Umemura T, Wada S, Tanaka E


A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature
J Infect Chemother,24(5):393-397 2018(May)
Author:Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E


Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma
Sci Rep,8(1):7958 2018(May)
Author:Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K


Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
Sci Rep,8(1):8159 2018(May)
Author:Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E


KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
Oncotarget,9(28):19650-19661 2018(Apr.)
Author:Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M


Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
World J Gastroenterol,24(13):1440-1450 2018(Apr.)
Author:Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E


Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society
Am J Transplant,18(3):659-668 2018(Mar.)
Author:Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, Kobayashi E, Tanaka E, Inomata Y, Kawasaki S, Shimada M, Kokudo N, Egawa H, Ohdan H, Uemoto S


Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
Hepatol Res,48(4):275-285 2018(Mar.)
Author:Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E


Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
World J Gastroenterol,24(11):1239-1249 2018(Mar.)
Author:Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E


長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の2例
信州医学雑誌,66(1):39-49 2018(Feb. 10)
Author:杉浦亜弓, 城下智, 山下裕騎, 木村岳史, 山崎智生, 藤森尚之, 小松通治, 松本晶博, 小林翔太, 梅村武司, 田中榮司


Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
Gut,67(2):362-371 2018(Feb.)
Author:Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M


Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy
J Gastroenterol,53(2):247-257 2018(Feb.)
Author:Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E


Genetics and epigenetics in the pathogenesis of primary biliary cholangitis
Clin J Gastroenterol,11(1):11-18 2018(Feb.)
Author:Joshita S, Umemura T, Tanaka E, Ota M


Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
PLoS One,13(4):e0195632 2018
Author:Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E


Salmonella Enteritidis cholecystitis with chronic granulomatous disease
IDCases,12:49-52 2018
Author:Yamashita Y, Kimura T, Tanaka N, Yazaki M, Itagaki T, Joshita S, Umemura T, Matsumoto A, Mori H, Wada S, Tanaka E


Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population
PLoS One,13(4):e0195778 2018
Author:Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M


Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
J Hum Genet,62(11):963-967 2017(Nov.)
Author:Umemura T, Joshita S, Hamano H, Yoshizawa K, Kawa S, Tanaka E, Ota M


Survival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan
Hepatol Res,47(11):1155-1164 2017(Oct.)
Author:Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y, The Assessment Committee of Indication for Transplantation


Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
Clin J Gastroenterol,10(5):452-458 2017(Oct.)
Author:Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E


【ウイルス肝炎のすべて】血液伝播するウイルス肝炎 B型肝炎 B型肝炎に対する核酸アナログ/インターフェロン併用療法
医学のあゆみ,262(14):1336-1340 2017(Sep.)
Author:梅村武司, 田中榮司


Association between lower air pressure and the onset of ischemic colitis: a case-control study
Eur J Gastroenterol Hepatol,29(9):1071-1078 2017(Sep.)
Author:Kimura T, Shinji A, Tanaka N, Koinuma M, Yamaura M, Nagaya T, Joshita S, Komatsu M, Umemura T, Horiuchi A, Wada S, Tanaka E


Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
Liver Int,37(6):897-905 2017(Jun.)
Author:Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M


6年間に40回以上の内視鏡的バルーン拡張術を要した食道慢性GVHDの1例
ENDOSCOPIC FORUM for digestive disease,33(1):51 2017(May)
Author:平山敦大, 菅智明, 大野和幸, 小林惇一, 齊藤博美, 日原 優, 横田有紀子, 伊東哲宏, 中村麗那, 北畠央之, 田中景子, 岡村卓磨, 田中榮司


【混合型肝癌をめぐる混乱の終焉を目指して】 混合型肝癌[ICD-0 code 8180/3(WHO2010)]の画像診断
肝・胆・膵,74(5):761-767 2017(May)
Author:上田和彦, 平塚真生子, 松枝清, 高澤豊, 笹平直樹, 齋浦明夫, 田中榮司, 宮川眞一


Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody
J Gastroenterol,52(3):376-384 2017(May)
Author:Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E


Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
Case Rep Gastroenterol,11(2):305-311 2017(May)
Author:Sugiura A, Wada S, Mori H, Kimura T, Matsuda Y, Tanaka N, Tanaka E, Kiyosawa K


Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
Hepatol Res,47(5):405-418 2017(Apr.)
Author:Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E


Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
Sci Rep,7:46705 2017(Apr.)
Author:Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Igarashi K, Tanaka E


【内科領域におけるウイルス感染症〜ウイルス感染症に対する最新の知識と治療〜】 日常遭遇することの多いウイルス感染症 肝炎領域 B型肝炎
日本内科学会雑誌,106(3):422-427 2017(Mar.)
Author:田中榮司


IgG4関連疾患における悪性腫瘍発症
長野県医学会雑誌,47:26-27 2017(Mar.)
Author:浅野純平, 渡邉貴之, 北野真希子, 中村晃, 伊藤哲也, 田中榮司


関節リウマチ治療中に発症した悪性リンパ腫の1例
長野県医学会雑誌,47:101 2017(Mar.)
Author:酒井均, 川上徹, 須藤祐里子, 仁科さやか, 妹尾紀子, 中澤英之, 田中榮司


Genome-wide association studies identify PRKCB as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population
Hum Mol Genet,23(3):650-659 2017(Feb.)
Author:Kawashima M, Hitomi Y, Aiba Y, Nishida N, Kojima K, Kawai Y, Nakamura H, Tanaka A, Zeniya M, Hashimoto E, Ohira H, Yamamoto K, Abe M, Nakao K, Yamagiwa S, Kaneko S, Honda M, Umemura T, Ichida T, Seike M, Sakisaka S, Harada M, Yokosuka O, Ueno Y, Senju M, Kanda T, Shibata H, Himoto T, Murata K, Miyake Y, Ebinuma H, Taniai M, Joshita S, Nikami T, Ota H, Kouno H, Kouno H, Nakamuta M, Fukushima N, Kohjima M, Komatsu T, Komeda T, Ohara Y, Muro T, Yamashita T, Yoshizawa K, Nakamura Y, Shimada M, Hirashima N, Sugi K, Ario K, Takesaki E, Naganuma A, Mano H, Yamashita H, Matsushita K, Yamauchi K, Makita F, Nishimura H, Furuta K, Takahashi N, Kikuchi M, Masaki N, Tanaka T, Tamura S, Mori A, Yagi S, Shirabe K, Komori A, Migita K, Ito M, Nagaoka S, Abiru S, Yatsuhashi H, Yasunami M, Shimoda S, Harada K, Egawa H, Maehara Y, Uemoto S, Kokudo N, Takikawa H, Ishibashi H, Chayama K, Mizokami M, Nagasaki M, Tokunaga K, Nakamura M


Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis
Clin J Gastroenterol,10(1):73-78 2017(Feb.)
Author:Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O


Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Hepatol Res,47(2):226-233 2017(Feb.)
Author:Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E


Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up
Clin J Gastroenterol,10(1):79-85 2017(Feb.)
Author:Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E


【エキスパートが教える薬の使い方×エビデンスの調べ方】 (第1章)よくある疾患に対する薬の使い分け 肝炎
薬事,59(2):280-284 2017(Jan.)
Author:梅村武司, 田中榮司


The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study
J Gastroenterol,52(1):113-122 2017(Jan.)
Author:Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O


Association between endotoxemia and histological features of nonalcoholic fatty liver disease
World J Gastroenterol,23(4):712-722 2017(Jan.)
Author:Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E


The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.
J Gastroenterol,52(1):113-122 2017(Jan.)
Author:Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O


Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
J Immunol Res,:3073504 2017
Author:Joshita S, Umemura T, Tanaka E, Ota M


Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis.
Clin J Gastroenterol,in press 2016(Dec.)
Author:Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O


Survival in patients with Child-Pugh class C cirrhosis: analysis of the liver transplant registry in Japan.
Hepatol Res,in press 2016(Dec.)
Author:Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y


Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.
Hepatol Res,46(12):1171-1186 2016(Nov.)
Author:Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E, Uemoto S; Japanese Liver Transplantation Society.


Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Liver Int,in press 2016(Nov.)
Author:Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M


Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up.
Clin J Gastroenterol,in press 2016(Nov.)
Author:Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E


Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
Gut,in press 2016(Oct.)
Author:Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M


Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
Hepatol Res,46(10):1019-27 2016(Sep.)
Author:Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E


Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations.
BMC Microbiol,16(1):224 2016(Sep.)
Author:Mori KI, Matsumoto A, Maki N, Ichikawa Y, Tanaka E, Yagi S


Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Hepatol Res,46(9):884-9 2016(Aug.)
Author:Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E


Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
Hepatol Res,46(9):878-83 2016(Aug.)
Author:Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M


A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
Clin J Gastroenterol,9(4):222-7 2016(Aug.)
Author:Yamazaki T, Iwaya Y, Iwaya M, Watanabe T, Seki A, Ochi Y, Hara E, Sekiguchi T, Hosaka N, Arakura N, Tanaka E, Hasebe O


Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years.
Dig Endosc,28(5):607-10 2016(Jul.)
Author:Iwaya Y, Yamazaki T, Watanabe T, Seki A, Ochi Y, Hara E, Arakura N, Tanaka E, Hasebe O


Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Springerplus,5(1):998 2016(Jul.)
Author:Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E


Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
Sci Rep,6:29770 2016(Jul.)
Author:Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, Tanaka E, Ota M


Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.
J Gastroenterol,in press 2016(Jul.)
Author:Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E


Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C.
Hepatology,63(6):2063-4 2016(Jun.)
Author:Shibata S, Umemura T, Komatsu M, Tanaka E


Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Hepatol Res,in press 2016(Jun.)
Author:Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E


A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy
信州医学雑誌,64(2):75-78 2016(Apr. 10)
Author:Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji


Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
Sci Rep,6:24767 2016(Apr.)
Author:Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, et al


Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Hepatol Res,in press 2016(Mar.)
Author:Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E


JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
Hepatol Res,46(2):129-65 2016(Feb.)
Author:Asahina Y, Izumi N, Hiromitsu K, Kurosaki M, Koike K, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H, Hayashi N, Hiramatsu N, Yotsuyanagi H


The loop-forming method as a useful technique to rotate the endoscopic insertion tube shaft.
Endosc Int Open,4(2):E170-4 2016(Feb.)
Author:Suga T, Okamura T, Arakura N, Tanaka E


Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
Dis Markers,2016:6485343 2016
Author:Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M


Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
Pathology,47(7):647-52 2015(Dec.)
Author:Maruyama Y, Uehara T, Daikuhara S, Kobayashi Y, Nakajima T, Matsumoto A, Tanaka E, Ota H


A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?
Pathol Res Pract,211(12):1034-9 2015(Dec.)
Author:Muraki T, Uehara T, Sano K, Oota H, Yoshizawa A, Asaka S, Tateishi A, Otsuki T, Shingu K, Matoba H, Kobayashi S, Ichimata S, Watanabe T, Itou T, Tanaka E


Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.
Hepatol Res,45(12):1195-202 2015(Dec.)
Author:Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E


Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.
Acta Histochem Cytochem,48(6):193-204 2015(Dec.)
Author:Daikuhara S, Uehara T, Higuchi K, Hosaka N, Iwaya M, Maruyama Y, Matsuda K, Arakura N, Tanaka E, Ota H


Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
J Gastroenterol Hepatol,30(10):1478-84 2015(Oct.)
Author:Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J


A case of acquired hemophilia A diagnosed after percutaneous endoscopic gastrostomy.
Clin J Gastroenterol,8(5):290-3 2015(Oct.)
Author:Okamura T, Komatsu M, Ito A, Ito T, Suga T, Arakura N, Sakai H, Tanaka E


Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
Clin Infect Dis,61(5):719-29 2015(Sep.)
Author:Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, et al


Primary hepatocellular carcinoma in a patient with neurofibromatosis type I.
Liver Int,35(8):2057-8 2015(Aug.)
Author:Kimura T, Tanaka N, Umemura T, Tanaka E


Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis.
Hepatol Res,45(7):739-44 2015(Jul.)
Author:Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E


Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Am J Gastroenterol,110(6):857-64 2015(Jun.)
Author:Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E


Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
PLoS One,10(6):e0131658 2015(Jun.)
Author:Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M


Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Biochim Biophys Acta,1852(3):473-81 2015(Mar.)
Author:Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T


Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
BBA Clin,3:168-74 2015(Feb.)
Author:Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E


Superficially located enlarged lymphoid follicles characterise nodular gastritis.
Pathology,47(1):38-44 2015(Jan.)
Author:Okamura T, Sakai Y, Hoshino H, Iwaya Y, Tanaka E, Kobayashi M


Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
World J Gastroenterol,21(2):541-8 2015(Jan.)
Author:Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E


Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
PLOS ONE,9(6):e100565 2014(Jun.)
Author:Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M


Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B
Hepatol Res,44(1):1-8 2014(Jan.)
Author:Tanaka, E; Matsumoto, A


STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
DISEASE MARKERS,2014:727393 2014
Author:Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M


Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
HEPATOLOGY RESEARCH,43(7):801-807 2013(Jul.)
Author:Joshita, S; Shirahata, K; Yazaki, Y; Okaniwa, S; Nakamura, Y; Kimura, T; Noami, S; Horigome, R; Yagi, H; Ito, N; Yamazaki, A; Akahane, Y; Umemura, T; Yoshizawa, K; Tanaka, E; Ota, M


Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography
DIGESTIVE ENDOSCOPY,25(2):189-196 2013(Mar.)
Author:Muraki, T; Arakura, N; Kodama, R; Yoneda, S; Maruyama, M; Itou, T; Watanabe, T; Maruyama, M; Matsumoto, A; Kawa, S; Tanaka, E


Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
HUMAN IMMUNOLOGY,74(2):219-222 2013(Feb.)
Author:Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M


Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
INTERNAL MEDICINE,52(17):1903-1908 2013
Author:Sekiguchi, N; Joshita, S; Yoshida, T; Kurozumi, M; Sano, K; Nakagawa, M; Ito, T; Matsushita, T; Komatsu, D; Komatsu, M; Ito, T; Umemura, T; Ikeda, S; Kadoya, M; Ishida, F; Tanaka, E


Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
J Gastroenterol,47(9):1006-1013 2012(Sep.)
Author:Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S


2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients
Ther Apher Dia,16(4):289-310 2012(Aug.)
Author:Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T


Helicobacter pylori-Negative Primary Rectal MALT Lymphoma: Complete Remission after Radiotherapy
Case Rep Gastroenterol,6(2):319-27 2012(Jul.)
Author:Okamura T, Suga T, Iwaya Y, Ito T, Yokosawa S, Arakura N, Ota H, Tanaka E


No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
BMC Med Genet,13:47 2012(Jun.)
Author:Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang J. H, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn S. H, Han K. H, Park J. Y, Yuen M. F, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K


Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
PLoS One,7(6):e39175 2012(Jun.)
Author:Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn S. H, Park J. Y, Hige S, Kang J. H, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M


Hepatic Cerebroside Sulfotransferase Is Induced by PPARalpha Activation in Mice
PPAR Res,:174932 2012(May)
Author:Kimura T, Nakajima T, Kamijo Y, Tanaka N, Wang L, Hara A, Sugiyama E, Tanaka E, Gonzalez Frank J, Aoyama T


Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-alpha inhibitors
Hepatol Res,42(4):333-339 2012(Apr.)
Author:Tanaka E, Urata Y


Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
HUMAN IMMUNOLOGY,73(3):298-300 2012(Mar.)
Author:Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Ichikawa, Yuki; Kimura, Takefumi; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Nozomi; Ota, Masao; Tanaka, Eiji


Long-term outcome of japanese patients with type 1 autoimmune hepatitis
,56(2):668-676 2012(Feb.)
Author:Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M


Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
Hepatology,55(2):506-511 2012(Feb.)
Author:Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E


Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
Hepatol Res,42(2):139-149 2012(Feb.)
Author:Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H


Assessment of safety of using antithrombotic agents during esophagogastroduodenoscopy: rationale and design of the ASAMA Study
Shinshu Medical Journal,60(3):143-148 2012
Author:Kasai H, Suga T, Ikeda U, Yoshioka J, Tanaka E, Akamatsu T, for the ASAMA study Investigators


Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.
J Gastroenterol,46(12):1353-1360 2011(Dec.)
Author:Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E


Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients
J Gastroenterol,46(10):1203-1212 2011(Oct.)
Author:Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H, P. B. C. Study Group in NHOSLJ


Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.
Antivir Ther,16(7):1073-1080 2011(Oct.)
Author:Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E


Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.
Intern Med,50(18):1953-1956 2011(Sep.)
Author:Iwaya Y, Takenaka K, Akamatsu T, Yamada Y, Haba S, Matsuda K, Nakazawa H, Muraki T, Kaneko Y, Ito T, Sano K, Arakura N, Tanaka E, Ishida F


Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
HEPATOLOGY RESEARCH,41(9):904-909 2011(Sep.)
Author:Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E


Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
HUMAN MOLECULAR GENETICS,20(17):3507-3516 2011(Sep.)
Author:Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M


Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy
JOURNAL OF GASTROENTEROLOGY,46(6):758-768 2011(Jun.)
Author:Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, Nagaya T, Komatsu M, Sano K, Miyagawa S, Aoyama T, Tanaka E


Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
HEPATOLOGY RESEARCH,41(6):587-593 2011(Jun.)
Author:Yoneda S, Umemura T, Joshita S, Ichijo T,Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E


Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b
JOURNAL OF MEDICAL VIROLOGY,83(5):871-878 2011(May)
Author:Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M


Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
JOURNAL OF INFECTIOUS DISEASES,203(8):1087-1095 2011(Apr.)
Author:Yoneda, Suguru; Umemura, Takeji; Katsuyama, Yoshihiko; Kamijo, Atsushi; Joshita, Satoru; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji


Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
HEPATOLOGY RESEARCH,41(4):350-357 2011(Apr.)
Author:Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E


Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
JOURNAL OF GASTROENTEROLOGY,46(Suppl 1):48-55 2011(Jan.)
Author:Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E


Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009
HEPATOLOGY RESEARCH,41(1):1-21 2011(Jan.)
Author:Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M


A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
INTERNAL MEDICINE,50(17):1815-1819 2011
Author:Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E


Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
JOURNAL OF GASTROENTEROLOGY,45(12):1263-1271 2010(Dec.)
Author:Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, Ueda K, Komatsu M, Nagaya T, Joshita S, Kodama R, Tanaka E, Uehara T, Sano K, Tanaka N


Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib
International Journal of Case Reports and Images,1(4):16-18 2010(Dec.)
Author:Kimura T, Umemura T, Ichijo T, Yamamura N, Tanaka E


Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,47(3):256-260 2010(Nov.)
Author:Akamatsu T, Nagaya T, Ichikawa S, Sudo T, Takeda R, Takenaka K, Kodama R, Ito T, Arakura N, Tanaka E


Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice
BIOCHEMICAL PHARMACOLOGY,80(10):1601-1612 2010(Nov.)
Author:Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T


Down-regulation of SREBP-1c is associated with the development of burned-out NASH
JOURNAL OF HEPATOLOGY,53(4):724-731 2010(Oct.)
Author:Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T


Chronic gastritis in the setting of autoimmune pancreatitis
AMERICAN JOURNAL OF SURGICAL PATHOLOGY,34(9):1241-1249 2010(Sep.)
Author:Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y, Tanaka E, Honda T, Ota H


Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
JOURNAL OF HEPATOLOGY,53(3):537-541 2010(Sep.)
Author:Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Nakamura, Minoru; Ishibashi, Hiromi; Ota, Masao


Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice.
Redox Rep,15(3):123-130 2010(Jul.)
Author:Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T


Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment
DIGESTIVE DISEASES AND SCIENCES,55(7):2095-2101 2010(Jul.)
Author:Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y


Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
JOURNAL OF CLINICAL GASTROENTEROLOGY,44(6):440-447 2010(Jul.)
Author:Tsutsui, Masaru; Tanaka, Naoki; Kawakubo, Masatomo; Sheena, Yo; Horiuchi, Akira; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji; Sano, Kenji


Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
JOURNAL OF GASTROENTEROLOGY,45(6):666-672 2010(Jun.)
Author:Tsuruta, Goro; Tanaka, Naoki; Hongo, Minoru; Komatsu, Michiharu; Horiuchi, Akira; Hamamoto, Kaeko; Iguchi, Chieko; Nakayama, Yoshiko; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji


A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
HUMAN IMMUNOLOGY,71(5):520-524 2010(May)
Author:Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao


A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
JOURNAL OF KOREAN MEDICAL SCIENCE,25(3):476-480 2010(Mar.)
Author:Joshita, Satoru; Nakazawa, Koh; Koike, Shoichiro; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Yoshizawa, Kaname; Tanaka, Eiji


Usefulness of double balloon enteroscopy and video capsule endoscopy for the diagnosis and management of primary follicular lymphoma of the gastrointestinal tract in its early stages
DIGESTIVE ENDOSCOPY,22(1):33-38 2010(Jan.)
Author:Akamatsu T, Kaneko Y, Ota H, Miyabayashi H, Arakura N, Tanaka E


Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
HEPATOLOGY RESEARCH,40(1):1-7 2010(Jan.)
Author:Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y


Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
HEPATOLOGY RESEARCH,40(1):8-13 2010(Jan.)
Author:Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y


Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B
ShinshuMed J,58(4):153-162 2010
Author:Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E


DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASH
JOURNAL OF HEPATOLOGY,52(Suppl. 1):S373-S374 2010
Author:Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.


CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
JOURNAL OF HEPATOLOGY,52(Suppl. 1):S286-S286 2010
Author:Umemura, T.; Kiyosawa, K.; Tanaka, E.; Grp, Japan Novo Hepatitis B. Res


A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
INTERNAL MEDICINE,49(11):991-994 2010
Author:Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi;Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji


Combination Chemotherapy with Low-dose 5-FU, Cisplatin, and Gemcitabine for Gemcitabine-Refractory Pancreatic Cancer
信州医学雑誌,57(6):247-253 2009(Dec.)
Author:Norikazu ARAKURA, Osamu HASEBE, Yasuhide OCHI, Hideaki HAMANO, Eiji TANAKA, Shigeyuki KAWA
Keywords:second-lin chemotherapy, pancreatic cancer, 5-FU, Cisplatin, Gemcitabine


Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
JOURNAL OF GASTROENTEROLOGY,44(9):952-963 2009(Sep.)
Author:Okanoue, Takeshi; Itoh, Yoshito; Hashimoto, Hiroaki; Yasui, Kohichiroh; Minami, Masahito; Takehara, Tetsuo; Tanaka, Eiji; Onji, Morikazu; Toyota, Joji; Chayama, Kazuaki; Yoshioka, Kentaro; Izumi, Namiki; Akuta, Norio; Kumada, Hiromitsu


A case of well-differentiated cholangiolocellular carcinoma visualizedwith contrast-enhanced ultrasonography using Sonazoid
HEPATOLOGY RESEARCH,39(2):207-212 2009(Feb.)
Author:Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji


Pancreaticobiliary Fistula Evident after ESWL Treatment of Pancreatolithiasis
INTERNAL MEDICINE,48(7):545-549 2009
Author:Arakura, N; Ozaki, Y; Maruyama, M; Chou, Y; Kodama, R; Takayama, M; Hamano, H; Tanaka, E; Kawa, S


Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults
INTERNAL MEDICINE,48(15):1267-1272 2009
Author:Nagaya, Tadanobu; Tanaka, Naoki; Kamijo, Atsushi; Joshita, Satoru; Nakazawa, Koh; Miyabayashi, Hideharu; Yoneda, Suguru; Ito, Tetsuya; Komatsu, Michiharu; Tanaka, Eiji; Kitano, Kiyoshi


Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
INTERNAL MEDICINE,48(21):1885-1888 2009
Author:Arakura, Norikazu; Ozaki, Yayoi; Yamazaki, Sachie; Ueda, Kazuhiko; Maruyama, Masafumi; Chou, Yoshimi; Kodama, Ryo; Takayama, Mari; Hamano, Hideaki; Tanaka, Eiji; Kawa, Shigeyuki


Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
LIVER INTERNATIONAL,28(8):1104-1111 2008
Author:Tanaka, N; Nagaya, T; Komatsu, M; Horiuchi, A; Tsuruta, G; Shirakawa, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Aoyama, T; Kiyosawa, K; Tanaka, E


Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
CLINICAL INFECTIOUS DISEASES,47(5):E52-E56 2008
Author:Umemura, T; Tanaka, E; Kiyosawa, K; Kumada, H


Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
JOURNAL OF CLINICAL GASTROENTEROLOGY,42(4):413-418 2008
Author:Tanaka, N; Sano, K; Horiuchi, A; Tanaka, E; Kiyosawa, K; Aoyama, T


Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis
Clinical Immunology,122(3):338-342 2007
Author:Umemura, T; Ota, M; Yoshizawa, K; Katsuyama, Y; Ichijo, T; Tanaka, E; Kawa, S; Kiyosawa, K


Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
Journal of Viral Hepatitis,14(1):48-54 2007
Author:Umemura, T; Muto, H; Tanaka, E; Matsumoto, A; Ichijo, T; Yoshizawa, K; Akamatsu, T; Kiyosawa, K


Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
JOURNAL OF MEDICAL VIROLOGY,78(1):68-73 2006
Author:Misawa, N; Matsumoto, A; Tanaka, E; Rokuhara, A; Yoshizawa, K; Umemura, T; Maki, N; Kimura, T; Kiyosawa, K


Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance
LIVER INTERNATIONAL,26(1):90-96 2006
Author:Tanaka, E; Matsumoto, A; Suzuki, F; Kobayashi, M;Mizokami, M; Tanaka, Y; Okanoue, T; Minami, M; Chayama, K; Imamura, M; Yatsuhashi, H; Nagaoka, S; Yotsuyanagi, H; Kawata, S; Kimura, T; Maki, N; Iino, S; Kiyosawa, K


Laparoscopic findings in patients with nonalcoholic steatohepatitis
LIVER INTERNATIONAL,26(1):32-38 2006
Author:Tanaka, N; Ichijo, T; Okiyama, W; Mutou, H; Misawa, N; Matsumoto, A; Yoshizawa, K; Tanaka, E; Kiyosawa, K


Timing of interferon therapy and sources of infection in patients with acute hepatitis C
HEPATOLOGY RESEARCH,34(1):35-40 2006
Author:Ogata, K; Ide, T; Kumashiro, R; Kumada, H; Yotsuyanagi, H; Okita, K; Akahane, Y; Kaneko, S; Tsubouchi, H;Tanaka, E; Moriwaki, H; Nishiguchi, S; Kakumu, S; Mizokami, M; Iino, S; Sata, M


Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
EUROPEAN JOURNAL OF HAEMATOLOGY,77(3):255-258 2006
Author:Kitano, K; Kobayashi, H; Hanamura, M; Furuta, K; Ueno, M; Rokuhara, A; Tanaka, E; Umemura, T; Kiyosawa, K


Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
HEPATOLOGY,44(2):326-334 2006
Author:Ozasa, A; Tanaka, Y; Orito, E; Sugiyama, M; Kang, JH; Hige, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Okada, S; Tokita, H; Asahina, Y; Inoue, K; Kakumu, S; Okanoue, T; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sakugawa, H; Miyakawa, Y; Ueda, R; Mizokami, M


Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
LIVER INTERNATIONAL,26(8):956-963 2006
Author:Tanaka, N; Tanaka, E; Sheena, Y; Komatsu, M; Okiyama, W; Misawa, N; Muto, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Horiuchi, A; Kiyosawa, K


Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
JOURNAL OF GASTROENTEROLOGY,41(8):785-790 2006
Author:Rokuhara, A; Matsumoto, A; Tanaka, E; Umemura, T; Yoshizawa, K; Kimura, T; Maki, N; Kiyosawa, K


Influence of hepatitis B virus genotypes as well as precore and core-promoter mutations on fulminant outcome of acute infection
HEPATOLOGY,44(4):539A-539A 2006
Author:Sugauchi, F; Orito, E; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Yotsuyanagi, H; Iino, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Izumi, N; Inoue, K; Kakumu, S; Tomita, E; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Okanoue, T; Nishiguchi, S; Miyakawa,Y; Mizokami, M


A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan
HEPATOLOGY,44(4):228A-228A 2006
Author:Yoshizawa, K; Yokosawa, S; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Matsumoto, A; Tanaka, E; Kiyosawa, K


Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
HEPATOLOGY RESEARCH,36(2):107-114 2006
Author:Sugauchi, F; Orito, E; Ohno, T; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Ichida, T; Izumi, N; Inoue, K; Hoshino, H; Iino, S; Yotsuyanagi, H; Kakumu, S; Tomita, E; Okanoue, T; Nishiguchi, S; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Miyakawa, Y; Ueda, R; Mizokami, M


Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection
ARCHIVES OF VIROLOGY,150(5):883-898 2005
Author:Higashi, K; Tsukiyama-Kohara, K; Tanaka, T; Tanaka, E; Kiyosawa, K; Kohara, M


Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan
INTERVIROLOGY,48(4):239-245 2005
Author:Orito, E; Sugauchi, F; Tanaka, Y; Ichida, T; Sata, M; Tanaka, E; Okanoue, T; Sakugawa, H; Watanabe, H; Miyakawa, H; Nishiguchi, S; Kumada, H; Ueda, R; Mizokami, M


Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
JOURNAL OF BIOLOGICAL CHEMISTRY,280(23):21713-21719 2005
Author:Kimura, T; Ohno, N; Terada, N; Rokuhara, A; Matsumoto, A; Yagi, S; Tanaka, E; Kiyosawa, K; Ohno, S; Maki, N


Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan
JOURNAL OF VIRAL HEPATITIS,12(4):439-442 2005
Author:Tanaka, E; Matsumoto, A; Takeda, N; Li, TC; Umemura, T; Yoshizawa, K; Miyakawa, Y; Miyamura, T; Kiyosawa, K


Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
HEPATOLOGY RESEARCH,32(3):173-184 2005
Author:Matsumoto, A; Tanaka, E; Rokuhara, A; Kiyosawa, K; Kumada, H; Omata, M; Okita, K; Hayashi, N; Okanoue, T; Iino, S; Tanikawa, K


Identification and quantitative analysis of a 22-KDA precore protein lacking C-terminal arginine-rich domain in hepatitis B virus DNA-negative Dane particles.
HEPATOLOGY,42(4):708A-708A 2005
Author:Kimura, T; Ohue, C; Ohno, N; Terada, N; Ohno, S; Akinori, R; Matsumoto, A; Tanaka, E; Kiyosawa, K; Maki, N


ウィルス性肝炎の治療の最前線
ヒューマンサイエンス,16:4-10 2005
Author:四柳 宏,田中榮司,横須賀 収


【C型肝炎の最新治療 治療方針のたて方と治療効果】治療方針とその効果 高ウイルス量の患者への治療方針と効果
消化器の臨床,8:180-183 2005
Author:松本晶博,田中榮司,清澤研道


【生活習慣病と非アルコール性脂肪肝炎(NASH)】脂肪肝と肝移植
Progress inMedicine,25:1657-1660 2005
Author:田中直樹,田中榮司,清澤研道


E型肝炎ウィルス(HEV)マーカー 広範囲血液・尿化学検査,免疫学的検査
日本臨床,63:421-423 2005
Author:田中榮司


信州大学病院において-ウィルス性肝炎移植の現状と問題点-
今日の移植,18:216-219 2005
Author:田中榮司


当科における肝細胞癌に対するラジオ波焼灼術の実態
長野県医学会雑誌,35:38-39 2005
Author:一條哲也,沖山 洋,武藤英知,三沢倫子,梅村武司,松本晶博,吉澤 要,田中榮司,清澤研道


Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis
J Hepatol,42(4):578-584 2005
Author:Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K


Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients
J Med Virol,77(3):399-413 2005
Author:Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K


Nucleotide mutations associated with hepatitis B e antigen negativity
J Med Virol,76(2):170-175 2005
Author:Sun X, Rokuhara A, Tanaka E, Gad A, Mutou H, Matsumoto A, Yoshizawa K, Kiyosawa K


Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection
J Gastroenterol Hepatol,20(11):1726-1730 2005
Author:Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K


Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma
Asia-Pacific Journal of clinical oncology,1:64-70 2005
Author:Gad A, Tanaka E, Matsumoto A, Serwah Ael-H , Attia F , Hassan A, Ali K , Abbas A, el-Deeb Ael- , Sun X, Umemura T, Ichijyo T, Ehara T, Yoshizawa K, Kiyosawa K


Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
WorldJ Gastroenterol,14:6607-6612 2005
Author:Gad A, Tanaka E, Matsumoto A, Wahab MA, Serwah Ael-H, Attia F, Ali K, Hassouba H, el-Deeb Ael-R, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K


Hepatitis B virus genotype G is an extremely rare genotype in Japan
HEPATOLOGY RESEARCH,30(4):199-203 2004
Author:Kato, H; Sugauchi, F; Ozasa, A; Kato, T; Tanaka, Y; Sakugawa, H; Sata, M; Hino, K; Onji, M; Okanoue, T; Tanaka, E; Kawata, S; Suzuki, K; Hige, S; Ohno, T; Orito, E; Ueda, R; Mizokami, M


C型肝硬変.血小板滅少例(血小板数58000~85000/μ 1)に対する少量INF-β療法の治療成績
飯田市立病院医誌,10:21-24 2004
Author:山浦高裕,一條哲也,海野 洋,岡庭信司,中村喜行,太田裕志,松尾恭介,六波羅明紀,松本晶博,吉澤 要,田中栄司,清澤研道


Hepatitis B virus covalently closed circuler DNAの定療法と臨床的意義
SRL宝函,28:175-179 2004
Author:向出雅一,松本晶博,六波羅明紀,田中栄司,竹村一男,兒崎隆純,引地一昌,清澤研道


C型肝炎ウイルス(HCV) C型慢性肝炎 予後に関連する因子の解析臨床検査データ
日本臨床,62:430-433 2004
Author:松本晶博,田中栄司,清澤研道


B型肝炎の治療up to date ラミブジン治療は肝発癌過程を修飾するか
臨床消化器内科,191:1507-1512 2004
Author:松本晶博,田中栄司,清澤研道


E型肝炎の概論
日本臨床,62:536-541 2004
Author:田中栄司


C型肝炎ウイルス(HCV) HCV抗原測定法 HCVコア抗原測定法とその臨床的有用性
日本臨床,62:208-213 2004
Author:田中栄司


C型肝炎 最近の動向
看護技術,50:11-15 2004
Author:田中栄司


B型慢性肝炎 HBe抗原陰性,肝機能異常を繰り返す症例に対する冶療
肝臓,45:397-401 2004
Author:田中栄司


B型肝炎の治療 B型肝炎診療Q&A HBe抗原陽性,高ウイルス量のB型慢性肝炎症例にいかに対処するか
臨床医,30:1601-1603 2004
Author:田中栄司


C型肝炎ウイルス 特殊型C型肝炎の臨床特論 HCV,HGV重複感染の疫学
日本臨床,62:677-681 2004
Author:折井幸司,田中栄司,清澤研道


我が国におけるSENウイルス感染の状況とその背景
日本臨床,62:602-605 2004
Author:梅村武司,田中栄司


SENウイルス(SEN V)の分子生物学
日本臨床,62:596-597 2004
Author:梅村武司,田中栄司


Wilson病の治療と発症予防
肝臓,45:459-462 2004
Author:梅村武司,田中栄司,清澤研道


Hepatic hydrothorax in the absence of ascites diagnosed by intraperitoneal spraying of indocyanine green
Intem Med,43(4):283-288 2004
Author:Umino J, Tanaka E, Ichijoh T, Muraki T, Orii K, Yoshizawa K, Kiyosawa K


Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C
N Engl J Med,350(12):1264-1265 2004
Author:Tanaka .N, Ishida F, Tanaka E


Nagano Interferon Treatment Research Group: Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C:analysis by a prospective study
J Gastroenterol,39(7):674-680 2004
Author:Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K


Hepatocellular carcinoma: recent trends in Japan
Gastroenteroiogy,127(5):S17-S26 2004
Author:Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E


Inteferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death
J ViralHepat,11(2):148-156 2004
Author:Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N


Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting abiochemical response
J Gastroenterol,39(11):1069-1077 2004
Author:Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N


Peroxisome proliferator-activated receptor a protects against alcohol-induced liver damage
Hepatology,40(4):972-980 2004
Author:Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, TanakaE, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T


Riskfactors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
JOURNAL OF HEPATOLOGY,38(2):200-207 2003
Author:Imamura, H; Matsuyama, Y; Tanaka, E; Ohkubo, T; Hasegawa, K; Miyagawa, S; Sugawara, Y; Minagawa, M; Takayama, T; Kawasaki, S; Makuuchi, M


Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities
HEPATOLOGY RESEARCH,25(2):124-134 2003
Author:Fujiwara, K; Yokosuka, O; Imazeki, F; Saisho, H; Saotome, N; Suzuki, K; Okita, K; Tanaka, E; Omata, M


Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; A marker distinct from viral DNA for monitoring lamivudine treatment.
HEPATOLOGY,38(4):726A-727A 2003
Author:Rokuhara, A; Kimura, T; Matsumoto, A; Tanaka, E; Maki, N; Kiyosawa, K


B型慢性肝炎に対するラミブジン治療のウイルス学的効果予測式の作成
肝臓,44:182-183 2003
Author:六波羅明紀,松本晶博,武藤英知,沖山 洋,田中直樹,丸山敦史,山浦高裕,折井幸司,一條哲也,吉澤 要,小林正和,袖山 健,田中榮司,清澤研道


Crohn病の良性狭窄病変に対する内視鏡的バルーン拡張術の検討
ENDOSCOPIC FORUM for digestive disease,19:167-173 2003
Author:村木 崇,赤松泰次,横澤秀一,三澤倫子,立岩伸之,進士明宏,小松健一,川村葉子,高山真理,浜野英明,越知泰英,中村 直,吉澤 要,田中榮司,清澤研道


NASHの成因と病態 肝炎ウイルスとNASH
臨床消化器内科,18:1269-1274 2003
Author:田中直樹,田中榮司,清澤研道


C型肝炎診断の新展開
Medical Technology,31:138-144 2003
Author:田中榮司


成人生体肝移植・ウイルス肝炎術後再発 予防と治療
今日の移植,16:473-478 2003
Author:清澤研道,田中榮司


その他のウイルスによる肝炎
臨床医,29:645-647 2003
Author:梅村武司,田中榮司


Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease
Tissue Antigens,61(2):159-165 2003
Author:Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T, Rokuhara A, Orii K, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K


A case-control study for early prediction ofhepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter
J Med Virol,70(4):545-552 2003
Author:Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K


Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
J Infect Dis,188(10):1545-1552 2003
Author:Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ


Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
J Viral Hepat,10(4):324-330 2003
Author:Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K


Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan
Clin Infect Dis,37(8):1067-1072 2003
Author:Malaty HM, Tanaka E, Kumagai T, Ota H, Kiyosawa K, Graham DY, Katsuyama T


New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA
J Clin Microbiol,41(5):1901-1906 2003
Author:Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N


Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence
J Med Virol,70(4):594-599 2003
Author:Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z, Kiyosawa K


Clinical significance of SEN virus infection in patients on maintenance haemodialysis
Nephrol Dial Transplant,18(2):348-352 2003
Author:Kobayashi N, Tanaka E, Umemura T, Matsumoto A, Iijima T, Higuchi M, Hora K, Kiyosawa K


Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes
CELL TRANSPLANTATION,11(5):407-415 2002
Author:Kakegawa, T; Ise, H; Sugihara, N; Nikaido, T; Negishi, N; Akaike, T; Tanaka, E


The role of SEN virus infection in various liver diseases from different geographical regions.
HEPATOLOGY,36(4):646A-646A 2002
Author:Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ


2度の帝王切開を契機に増悪したと考えられる巨大肝血管腫によるKasabach-Merritt症候群の1例
肝臓,43:185-191 2002
Author:六波羅明紀,吉澤 要,山浦高裕,丸山敦史,折井幸司,一條哲也,田中榮司,角谷眞澄,清澤研道


慢性肝炎診療マニュアルをめぐって 肝炎ウイルスの血液感染/母子感染/その他
綜合臨床,51:1929-1934 2002
Author:田中榮司


ウイルス性肝炎の現況 SENウイルスとその臨床的意義
医学のあゆみ,200:33-36 2002
Author:田中榮司


HCV関連マーカー測定法の進歩
臨床検査,46:243-250 2002
Author:田中榮司


HCV感染の診断と検査 HCVコア抗原定量とHCVセログループ その利用法
臨床医,28:47-49 2002
Author:田中榮司


NASHと非A非B非C型肝炎ウイルス
肝・胆・膵,44:471-476 2002
Author:田中直樹,田中榮司,清澤研道


Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
Cancer,95(10):2243-2251 2002
Author:Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K


Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy
J Gastroenterol Hepatol,17(11):1229-1235 2002
Author:Yamaura T, Matsumoto A, Rokuhara A, Ichijo T, Tanaka E, Hanazaki K, Kajikawa S, Kiyosawa K


SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C
Hepatology,35(4):953-959 2002
Author:Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K


Characteristics of hepatocellular carcinoma in Japan
Oncology,62:5-7 2002
Author:Kiyosawa K, Tanaka E


Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
J Clin Microbiol,40(2):439-445 2002
Author:Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N


Epidemiology and clinical aspects on hepatitis C
Jpn J Infect Dis,55(3):69-77 2002
Author:Higuchi M, Tanaka E, Kiyosawa K


Clinical significance of TT virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection
Hepatol Res,22(1):13-19 2002
Author:Gad A, Tanaka E, Orii K, Rokuhara A, Nooman Z, El-Hamid Serwah A,El-Sherif A, El-Essawy M, Yoshizawa K, Kiyosawa K


Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B
JOURNAL OF GASTROENTEROLOGY,36(2):139-141 2001
Author:Kiyosawa, K; Tanaka, E


Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
FOOD AND CHEMICAL TOXICOLOGY,39(6):557-561 2001
Author:Hosaka, S; Kawa, S; Aoki, Y; Tanaka, E; Yoshizawa, K; Karasawa, Y; Hosaka, N


A birth cohort study of the seroepidemiologic association of Helicobacter pylori infection and Hepatitis A virus in rural Japan
GASTROENTEROLOGY,120(5):A128-A128 2001
Author:Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, ET; Kiyosawa, K; Graham, DY; Katsuyama, T


Development of a sensitive enzyme-immunoassay for hepatitis B virus core-related antigens.
CLINICAL CHEMISTRY,47(6):A94-A94 2001
Author:Kimura, T; Rokuhara, A; Sakamoto, Y; Yagi, S; Tanaka, E; Kiyosawa, K; Maki, N


Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
HEPATOLOGY,34(3):590-594 2001
Author:Orito, E; Ichida, T; Sakugawa, H; Sata, M; Horiike, N; Hino, K; Okita, K; Okanoue, T; Iino, S; Tanaka, E; Suzuki, K; Watanabe, H; Hige, S; Mizokami, M


8-year birth cohort study of the seroepidemiology of Helicobacter pylori infection and hepatitis A virus in rural Japan
GUT,49:A32-A32 2001
Author:Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, T; Kiyosawa, K; Graham, DY


SEN virus infection in high- and non-endemic areas for hepatitis C in Japan.
HEPATOLOGY,34(4):487A-487A 2001
Author:Umemura, T; Alter, HJ; Tanaka, E; Yeo, AE; Shih, JW; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K


Association between SEN virus infection and hepatitis C in Japan
JOURNAL OF INFECTIOUS DISEASES,184(10):1246-1251 2001
Author:Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K


Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect
JOURNAL OF GASTROENTEROLOGY,36(11):753-758 2001
Author:Gad, A; Tanaka, E; Orii, K; Rokuhara, A; Nooman, Z; Serwah, AH; Shoair, M; Yoshizawa, K; Kiyosawa, K


Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay
J Gastroenterol,36(5):317-321 2001
Author:Tanaka E 他10名


Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,15(3):311-319 2000
Author:Iijima, A; Tanaka, E; Kobayashi,M; Yagi, S; Mizokami, M; Kiyosawa, K


Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection
JOURNAL OF CLINICAL MICROBIOLOGY,38(5):1971-1973 2000
Author:Malaty, HM; Kumagai, T; Tanaka, E; Ota, H; Kiyosawa, K; Graham, DY; Katsuyama, T


Analysis of T cell repertoire in the liver of patients with chronic hepatitis C
CLINICAL AND EXPERIMENTAL IMMUNOLOGY,121(1):120-126 2000
Author:Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa,K


Risk factors contributing to early and late phases of intrahepatic recurrence of hepatocellular carcinoma (HCC) after hepatectomy.
GASTROENTEROLOGY,118(4):A916-A916 2000
Author:Imamura, H; Tanaka, E; Matsuyama, Y; Miyagawa, SI; Kawasaki, S; Kubota, K; Takayama, T; Makuuchi, M


T cell repertoire in the liver of patients with primary biliary cirrhosis
HUMAN IMMUNOLOGY,61(7):675-683 2000
Author:Inada, H; Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Tanaka, E; Kiyosawa, K


A new era of interferon treatment for chronic hepatitis C is coming
JOURNAL OF GASTROENTEROLOGY,35(8):652-654 2000
Author:Kiyosawa, K; Tanaka, E


The role of hepatitis C virus infection in glomerulopathy
HEPATOLOGY RESEARCH,18(3):190-202 2000
Author:Muramatsu, T; Hora, K; Ako, S; Tachibana, N; Hora, K; Tanaka, E


De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome
JOURNAL OF MEDICAL VIROLOGY,62(4):471-478 2000
Author:Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K


De novo infection of hepatitis B virus in patients with orthotopic liver transplantation analysis by determining the complete sequence of the genome.
HEPATOLOGY,32(4):597A-597A 2000
Author:Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K


The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease.
HEPATOLOGY,32(4):381A-381A 2000
Author:Umemura, T; Yeo, AE; Shih, Y; Matsumoto, A; Orii, K; Tanaka, E; Kiyosawa, K; Primi, D


Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,15(11):1292-1297 2000
Author:Nishizawa, Y; Tanaka, E; Orii, K; Rokuhara, A; Ichijo, T; Yoshizawa, K; Kiyosawa, K


Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA
Hepatology,32(2):388-393 2000
Author:Tanaka E 他6名


Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus
Intervirology,43(3):139-145 2000
Author:Orii K, Tanaka E 他5名


Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt
J Med Virol,60(2):177-181 2000
Author:Amal G, Tanaka E 他6名


Natural history of acute hepatitis C
J Gastroenterol Hepatol,15 (suppl):E97-E104 2000
Author:Tanaka E 他1


Detection of GB virus-C hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue
JOURNAL OFMEDICAL VIROLOGY,57(2):114-121 1999
Author:Kobayashi, M; Tanaka, E; Nakayama, J; Furuwatari, C; Katsuyama, T; Kawasaki, S; Kiyosawa, K


TT virus infection in an area of high-endemicity for hepatitisC
HEPATOLOGY RESEARCH,13(3):212-220 1999
Author:Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K


Transmission of and liver injury by TT virus in patients on maintenance hemodialysis
JOURNAL OF GASTROENTEROLOGY,34(2):234-240 1999
Author:Oguchi, T; Tanaka, E; Orii, K; Kobayashi, M; Hora, K; Kiyosawa, K


Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
HEPATOLOGY RESEARCH,14(2):161-170 1999
Author:Orii, K; Tanaka, E; Umemura, T; Rokuhara, A; Iijima, A; Yoshizawa, K; Imai, H; Kiyosawa, K


Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
JOURNAL OF CLINICAL MICROBIOLOGY,37(6):1802-1808 1999
Author:Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S


Transfusion-associated TT virus infection and its relationship to liver disease
HEPATOLOGY,30(1):283-288 1999
Author:Matsumoto, A; Yeo, AET; Shih, JWK; Tanaka, E; Kiyosawa, K; Alter, HJ


Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination
DNA AND CELL BIOLOGY,18(8):611-621 1999
Author:Vidalin, O; Tanaka, E; Spengler, U; Trepo, C; Inchauspe, G


GB virus C/hepatitis G virus
INTERVIROLOGY,42(2-3):185-195 1999
Author:Kiyosawa, K; Tanaka, E


T cell repertoire in the liver ofpatients with autoimmune hepatitis
HUMAN IMMUNOLOGY,60(9):806-815 1999
Author:Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Umemura, T; Tanaka, E; Kiyosawa, K


Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
JOURNAL OF GENERAL VIROLOGY,80:3007-3018 1999
Author:Rumin, S; Berthillon, P; Tanaka, E; Kiyosawa, K; Trabaud, MA; Bizollon, T; Gouillat, C; Gripon, P; Guguen-Guillouzo, C; Inchauspe, G; Trepo, C


Does GBV-C/HGV replicate in the liver?
JOURNAL OF GASTROENTEROLOGY,34(6):721-723 1999
Author:Tanaka, E


Adult-to-child transmission of Helicobacter pylori infection: Results from an 8-year birth cohort study.
GASTROENTEROLOGY,114(4):A211-A211 1998
Author:Malaty, HM; Graham, DY; Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T


Acquisition and loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study.
GASTROENTEROLOGY,114(4):A190-A190 1998
Author:Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T


Two patients with acute hepatitis B with suspected sexual transmission of hepatitis G virus
JOURNAL OF GASTROENTEROLOGY,33(3):419-423 1998
Author:Tanaka, E; Nakatsuji, Y; Kobayashi, M; Orii, K; Kiyosawa, K


Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C
JOURNAL OF GASTROENTEROLOGY,33(4):508-511 1998
Author:Kobayashi, M; Tanaka, E; Matsumoto, A; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K


Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance haemodialysis: Comparison among haemodialysis units
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,13(6):604-609 1998
Author:Kobayashi, M; Tanaka, E; Oguchi, H; Hora, K; Kiyosawa, K


Acquisition versus loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
JOURNAL OF INFECTIOUS DISEASES,178(3):717-721 1998
Author:Kumagai, T; Malaty, HM; Graham, DY; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T


An 8-year birth cohort study shows adult-to-child transmission of H-pylori infection
GUT,43:A40-A40 1998
Author:Malaty, HM; Kumagai, T; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T


Acquistion vs. loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
GUT,43:A39-A39 1998
Author:Kumagai, T; Malaty, HM; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T


Development of highly sensitive enzyme-immunoassay for hepatitis C virus core antigen.
HEPATOLOGY,28(4):568A-568A 1998
Author:Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S


Clinical performance of quantitative and highly sensitive HCV core antigen assay system.
HEPATOLOGY,28(4):279A-279A 1998
Author:Tanaka, E; Aoyagi, K; Nishizawa, Y; Umemura, T; Orii, K; Rokuhara, A; Iijima, A; Imai, H; Yoshizawa, K; Yagi, S; Hasegawa, A; Kiyosawa, K


T cell receptor usage of liver infiltrating T cells in patients with autoimmune hepatitis.
HEPATOLOGY,28(4):191A-191A 1998
Author:Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Imai, H; Tanaka, E; Kiyosawa, K


Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case
TRANSPLANTATION PROCEEDINGS,30(7):3321-3323 1998
Author:Kita, Y; Lake, JR; Ferrell, LD; Mori, M; Roberts, JP; Kakizoe, S; Kiyosawa, K; Tanaka, E; Shiga, J; Takikawa, H; Inoue, Y; Ohtake, T; Ohtomo, K; Yotsuyanagi, H; Oka, T; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Hashikura, Y; Kawasaki, S; Ascher, NL; Makuuchi, M


Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic
J Clin Microbiol,36(1):110-114 1998
Author:Tanaka E 他8名


Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis
J Viral Hepatitis,5(3):153-159 1998
Author:TANAKA Eiji 他7名


Hepatitis G virus GB virus C infection in patients with chronic non-B, non-C hepatitis
INTERNATIONAL HEPATOLOGY COMMUNICATIONS,6(3-4):137-143 1997
Author:Tanaka, E; Yamaguchi, K; Uemura, K; Kobayashi, M; Iijima, A; Kiyosawa, K; Yagi, S; Hasegawa, A


Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,12(1):73-76 1997
Author:Kobayashi, M; Tanaka, E; Matsumoto, A; Ichijo, T; Kiyosawa, K


Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection
INTERNATIONAL HEPATOLOGY COMMUNICATIONS,6(5):219-224 1997
Author:Ichijo, T; Nakatsuji, Y; Tanaka, E; Alter, HJ; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K


A prospective trial to change the administration dose of interferon according to a decrease in serum HCV-RNA in chronic hepatitis C.
GASTROENTEROLOGY,112(4):A1386-A1386 1997
Author:Sodeyama, T; Matsumoto, A; Tanaka, E; Iizima, A; Yoshizawa, K; Imai, H; Kiyosawa, K


Quantitative measurement of HCV RNA in the serum: A comparison of three assays based on different principles
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,12(7):500-506 1997
Author:Ichijo, T; Matsumoto, A; Kobayashi, M; Furihata, K; Tanaka, E


Hepatitis G virus GB virus C infection in an area of high endemic hepatitis C virus infection
HEPATOLOGY RESEARCH,7(2):130-135 1997
Author:Tanaka, E; Nakatsuji, Y; Kobayashi, M; Iijima, A; Ichijo, T; Imai, H; Yoshizawa, K; Sodeyama, T; Kiyosawa, K


Long-term prognosis of type C chronic hepatitis patients treated with interferon; Development of hepatocellular carcinoma.
HEPATOLOGY,26(4):1599-1599 1997
Author:Iijima, A; Sodeyama, T; Inada, H; Ichijo, T; Kobayashi, M; Yamada, S; Imai, H; Yoshizawa, K; Tanaka, E; Kiyosawa, K


Past and present infections ofhepatitis G virus in high-endemic area for hepatitis C; Comparison with nonendemic area.
HEPATOLOGY,26(4):797-797 1997
Author:Tanaka, E; Tacke, M; Kobayashi, M; Nakatsuji, Y; Kiyosawa, K; Schmolke, S; Engel, AM; Hess, G; Alter, HJ


Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery frominfection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors
HEPATOLOGY,26(6):1626-1633 1997
Author:Tacke, M; Schmolke, S; Schlueter, V; Sauleda, S; Esteban, JI; Tanaka, E; Kiyosawa, K; Alter, HJ; Schmitt, U; Hess, G; OfenlochHaehnle, B; Engel, AM


Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,12(11):762-765 1997
Author:Ideura, T; Tanaka, E; Nakatsuji, Y; Kobayashi, M; Kanno, Y; Oguchi, H; Hora, K


Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
JOURNAL OF IMMUNOLOGICAL METHODS,190(1):79-89 1996
Author:Kashiwakuma, T; Hasegawa, A; Kajita, T; Takata, A; Mori, H; Ohta, Y; Tanaka,E;Kiyosawa, K; Tanaka, T; Tanaka, S; Hattori, N; Kohara, M


Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,11(8):697-704 1996
Author:Mori, H; Yabu, K; Yoshizawa, K; Tanaka, E; Kiyosawa, K


Hepatitis G virus (HGV) infection in Japanese patients infected with hepatitis C virus (HCV).
HEPATOLOGY,24(4):403-403 1996
Author:Nakatsuji, Y; Shih, JWK; Kobayashi, M; Tanaka, E; Kiyosawa, K; Kim, JP; Alter, HJ


Effect of hepatitis G virus co-infection on patients with chronic hepatitis C
HEPATOLOGY,24(4):400-400 1996
Author:Tanaka, E; Alter, HJ; Nakatsuji, Y; Shih, JWK; Kim, JP; Matsumoto, A; Kobayashi, M; Kiyosawa, K


Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
THROMBOSIS AND HAEMOSTASIS,76(4):545-548 1996
Author:Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K


Prevalence and disease association of hepatitis G virus infection in Japan
JOURNAL OF VIRAL HEPATITIS,3(6):307-316 1996
Author:Nakatsuji, Y; Shih, JWK; Tanaka, E; Kiyosawa, K; Wages, J; Kim, JP; Alter, HJ


Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient with myeloproliferative disorder
INTERNAL MEDICINE,35(11):871-875 1996
Author:Usui, T; Kitano, K; Midorikawa, T; Yoshizawa, K; Kobayashi, H; Tanaka, E; Matsunami, H; Kawasaki, S; Kiyosawa, K


The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses
Hepatology,23(4):695-699 1996
Author:Kobayashi M, Tanaka E 他4名


Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
Hepatology,23(6):1330-1333 1996
Author:Tanaka E 他7名


Effect of hepatitis G virus infection on chronic hepatitis C
Ann Intern Med,125(9):740-743 1996
Author:Tanaka E 他8名


USEFULNESS OF SIMPLE ASSAYS FOR SERUM CONCENTRATION OF HEPATITIS-C VIRUS-RNA AND HCV GENOTYPE IN PREDICTING THE RESPONSE OF PATIENTS WITH CHRONIC HEPATITIS-C TO INTERFERON ALPHA-2A THERAPY
JOURNAL OF MEDICAL VIROLOGY,46(2):162-168 1995
Author:SUZUKI, T; TANAKA, E; MATSUMOTO, A; URUSHIHARA, A; SODEYAMA, T


SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA
HEPATOLOGY,22(4):996-996 1995
Author:TANAKA, T; LAU, JYN; MIZOKAMI, M; ORITO, E; TANAKA, E; KIYOSAWA, K; YASUI, K; OHTA, Y; HASEGAWA, A; TANAKA, S; KOHARA, M


CLINICAL-APPLICATION OF A FLUORESCENCE ENZYME-IMMUNOASSAY FOR HCV CORE PROTEIN
HEPATOLOGY,22(4):995-995 1995
Author:TANAKA, E; MATSUMOTO, A; KOBAYASHI, M; ICHIJO, T; IMAI, H; SODEYAMA, T; KIYOSAWA, K; OHTA, Y; HASEGAWA, A; KOHARA, M


PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN JAPAN
HEPATOLOGY,22(4):303-303 1995
Author:NAKATSUJI, Y; SHIH, JWK; TANAKA, E; WAGES, J; KIYOSAWA, K; KIM, JP; ALTER, HJ


ACUTE HEPATITIS-C TRANSMITTED BY NEEDLESTICK ACCIDENT DESPITE SHORT-DURATION INTERFERON TREATMENT
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,10(5):609-611 1995
Author:NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; MATSUMOTO, A; ICHIJO, T; MIZOKAMI, M; FURUTA, S


EPIDEMIOLOGY OF GENOTYPES OF HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITHTYPE-C CHRONIC LIVER-DISEASES - A MULTI-INSTITUTION ANALYSIS
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,10(5):538-545 1995
Author:TANAKA, E; KIYOSAWA, K; MATSUSHIMA, T; ISHIKAWA, K; HINO, K; TANAKA, S; NOSE, H; KUMADA, H; IINO, S; KAMIMURA, T; UNOURA, M; MIZOKAMI, M; OKANOUE, T; KUROKI, T; YAMADA, G; MIURA, T; YANO, M; TSUBOUCHI, H; KOHARA, M; SATO, S; HATTORI, N; FURUTA, S; KARINO, Y; SAINOKAMI, S; TANAKA, T; OKADA, S; CHAYAMA, K; YASUDA, K; KUWANA, K; KANEKO, S; MIZOGUCHI, N; YASUI, K; TAKEDA, T; KISHI, F; YATSUHASHI, H; MARUYAMA, T; TSUKIYAMAKOHARA, K


Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
BLOOD,86(10):3621-3621 1995
Author:Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K


Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia
JOURNAL OF HEPATOLOGY,23(6):742-745 1995
Author:Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M


QUANTITATIVE ASSAY FOR ANTI-HCV-CORE ANTIBODY IN HEALTHY-INDIVIDUALS FOUND ANTI-HCV POSITIVE DURING A MASS-SCREENING
INTERNATIONAL HEPATOLOGY COMMUNICATIONS,2(1):47-51 1994
Author:URUSHIHARA, A; SUZUKI, T; MATSUMOTO, A; TANAKA, E; SODEYAMA, T; KIYOSAWA, K; FURUTA, S


TYPE C CHRONIC HEPATITIS ASSOCIATED WITH THROMBOCYTOPENIA IN 2 PATIENTS
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,9(1):99-104 1994
Author:YABU, K; KIYOSAWA, K; AKO, S; USUDA, S; YOSHIZAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S


CHANGES IN ANTIBODY-TITERS TO HEPATITIS-C VIRUS FOLLOWING INTERFERON THERAPY FOR CHRONIC INFECTION
JOURNAL OF MEDICAL VIROLOGY,42(4):348-356 1994
Author:URUSHIHARA, A; SODEYAMA, T; MATSUMOTO, A; TANAKA, E


SILENT HEPATITIS-B VIRUS MUTANTS ARE RESPONSIBLE FOR NON-A, NON-B, NON-C, NON-D, NON-E HEPATITIS
MICROBIOLOGY AND IMMUNOLOGY,38(4):281-285 1994
Author:UCHIDA, T; SHIMOJIMA, M; GOTOH, K; SHIKATA, T; TANAKA, E; KIYOSAWA, K


ADAPTATION OF HEPATITIS-C VIRUS FOR PERSISTENT INFECTION IN PATIENTS WITH ACUTE HEPATITIS
GASTROENTEROLOGY,106(5):1344-1348 1994
Author:YAMAGUCHI, K; TANAKA, E; HIGASHI, K; KIYOSAWA, K; MATSUMOTO, A; FURUTA, S; HASEGAWA, A; TANAKA, S; KOHARA, M


SERUM COLLAGEN TYPE-IVFOR THE ASSESSMENT OF FIBROSIS AND RESISTANCE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,29(5):474-479 1994
Author:YABU, K; KIYOSAWA, K; MORI, H; MATSUMOTO, A; YOSHIZAWA, K; TANAKA, E; FURUTA, S


TRANSMISSION OF HEPATITIS-C IN AN ISOLATED AREA IN JAPAN - COMMUNITY-ACQUIRED INFECTION
GASTROENTEROLOGY,106(6):1596-1602 1994
Author:KIYOSAWA, K; TANAKA, E; SODEYAMA, T; YOSHIZAWA, K; YABU, K; FURUTA, K; IMAI, H; NAKANO, Y; USUDA, S;UEMURA, K; FURUTA, S; WATANABE, Y; WATANABE, J; FUKUDA, Y; TAKAYAMA, T; URUSHIBARA, A; MATSUMOTO, A; MORI, H; KOBAYASHI, M; SUZUKI, T; YAMADA, S; SEKI, T; SHIMIZU, S; NAKAMURA, M; SONE, H; HARA, K; ICHIJO, T; OHIKE, Y; GIBO, Y; NAKATSUJI, Y; YODA, H; TSUCHIYA, K; HAYATA, T; IMAI, Y; KOBAYASHI, M; HARA, N


VIRAL AND HOST FACTORS THAT CONTRIBUTE TO EFFICACY OF INTERFERON-ALPHA(2A) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
DIGESTIVE DISEASES AND SCIENCES,39(6):1273-1280 1994
Author:MATSUMOTO, A; TANAKA, E; SUZUKI, T; OGATA, H; KIYOSAWA, K


PREVALENCE OF HEPATITIS-C VIRUS WITH DIFFERENT GENOTYPES DETERMINED BY A GROUP-SPECIFIC ANTIBODY-ASSAY IN JAPANESE PATIENTS WITH CHRONIC LIVER-DISEASES DUE TO HEPATITIS-C VIRUS-INFECTION
JAPANESE JOURNAL OF MEDICAL SCIENCE&BIOLOGY,47(1):47-57 1994
Author:TANAKA, E; KIYOSAWA, K; MATSUMOTO, A; SODEYAMA, T; URUSHIHARA, A; SUZUKI, T; KOBAYASHI, M; FURUTA, S


IMMUNOPEROXIDASE STAINING OF HEPATITIS-C VIRUS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED NEEDLE LIVER BIOPSIES
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY,424(5):465-469 1994
Author:UCHIDA, T; SHIKATA, T; TANAKA, E; KIYOSAWA, K


NATURAL-HISTORY OF HEPATITIS-C
INTERVIROLOGY,37(2):101-107 1994
Author:KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S


CLINICAL-SIGNIFICANCE OF ANTIBODIES TO NONSTRUCTURAL AND CORE PROTEINS OF HEPATITIS-C VIRUS IN POSTTRANSFUSION HEPATITIS PATIENTS DURING LONG-TERM FOLLOW-UP
JOURNAL OF MEDICAL VIROLOGY,39(4):318-324 1993
Author:TANAKA, E; KIYOSAWA, K; NAKATSUJI, Y; INOUE, Y; MIYAMURA, T; CHIBA, J; FURUTA, S


COMPARISON OF THE CLINICAL AND IMMUNOGENETIC FEATURES BETWEEN PATIENTS WITH AUTOIMMUNE HEPATITIS AND PATIENTS WITH TYPE-C CHRONICACTIVE HEPATITIS
GASTROENTEROLOGIA JAPONICA,28:63-68 1993
Author:KIYOSAWA, K; SEKI, T; TANAKA, E; SODEYAMA, T; FURUTA, K; FURUTA, S; HINO, K; OTA, M; INOKO, H


ANTI-C100 ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION TREATED WITH INTERFERON
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,28(4):335-342 1993
Author:NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; YOSHIZAWA, K; FURUTA, K; NAKATSUJI, Y; URUSHIHARA, A; FURUTA, S


COMPARISON OF SEROEPIDEMIOLOGY OF HEPATITIS-C IN BLOOD-DONORS BETWEEN BANGLADESH AND JAPAN
GASTROENTEROLOGIA JAPONICA,28:28-31 1993
Author:KHAN, M; HUSAIN, M; YANO, M; HASHIZUME, K; YOUSUF, M; TANAKA, E; MATSUMOTO, A; FURUTA, S; KIYOSAWA, K


PROLIFERATIVE ACTIVITY OF HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS AS REVEALED BY IMMUNOHISTOCHEMISTRY FOR PROLIFERATING CELL NUCLEAR ANTIGEN
HUMAN PATHOLOGY,24(7):750-753 1993
Author:NAKAMURA, T; HAYAMA, M; SAKAI, T; HOTCHI, M; TANAKA, E


ASSOCIATION OF PRIMARY BILIARY-CIRRHOSIS WITH HUMAN-LEUKOCYTE ANTIGEN-DPB1-ASTERISK-0501 IN JAPANESE PATIENTS
HEPATOLOGY,18(1):73-78 1993
Author:SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; KUMAGAI, T; MIZUKI, N; ANDO, A; INOKO, H


DETECTION OF HEPATITIS-C VIRUS MARKERS AND HEPATITIS-C VIRUS GENOMIC RNA AFTER NEEDLESTICK ACCIDENTS
ARCHIVES OF INTERNAL MEDICINE,153(13):1565-1572 1993
Author:SODEYAMA, T; KIYOSAWA, K; URUSHIHARA, A; MATSUMOTO, A; TANAKA, E; FURUTA, S; AKAHANE, Y


PROGNOSIS OF ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN CARRIERS
ANNALS OF INTERNAL MEDICINE,119(6):535-535 1993
Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E


LOW-PREVALENCE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-1
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,8(5):442-447 1993
Author:TANAKA, E; KIYOSAWA, K; SEKI, T; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; KUMAGAI, T; KOHARA, M


FACTORS THAT CONTRIBUTE TO THE EFFICACY OF IFN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
HEPATOLOGY,18(4):A258-A258 1993
Author:TANAKA, E; MATSUMOTO, A; SUZUKI, T; URUSHIHARA, A; YOSHIZAWA, K; SODEYAMA, T; KIYOSAWA, K; FURUTA, S


IMMUNE-RESPONSES TO HCV ANTIGENS OF THE PATIENTS WITH DIFFERENT HISTOLOGICAL STAGES IN CHRONIC HEPATITIS-C
HEPATOLOGY,18(4):A245-A245 1993
Author:MORI, H; YABU, K; YOSHIZAWA, K; USUDA, S; TANAKA, E; KIYOSAWA, K; HASEGAWA, A; KOHARA, M; FURUTA, S


HUMAN-LEUKOCYTE ANTIGEN CLASS-II MOLECULES AND PRIMARY BILIARY-CIRRHOSIS SUSCEPTIBILITY IN JAPANESE PATIENTS
HEPATOLOGY,18(4):A218-A218 1993
Author:SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; MIZUKI, N; ANDO, A; INOKO, H


HIGH PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HEAVY DRINKERS WITH CHRONIC LIVER-DISEASES IN JAPAN
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,7(1):30-35 1992
Author:SHIMIZU, S; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, M


PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE SCHOOLCHILDREN - COMPARISON WITH ADULT-BLOODDONORS
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE,46(4):460-464 1992
Author:TANAKA, E; KIYOSAWA, K; SODEYAMA, T; HAYATA, T; OHIKE, Y; NAKANO, Y; YOSHIZAWA, K; FURUTA, S; WATANABE, Y; WATANABE, I; NISHIOKA, K


HEPATITIS-VIRUS INFECTION (HBV AND HCV) IN 11 JAPANESE HEMODIALYSIS UNITS
CLINICAL NEPHROLOGY,38(1):36-43 1992
Author:OGUCHI, H; MIYASAKA, M; TOKUNAGA, S;HORA, K; ICHIKAWA, S; OCHI, T; YAMADA, K; NAGASAWA, M; KANNO, Y; AIZAWA, T; WATANABE, H; YOSHIZAWA, S; SATO, K; TERASHIMA, M; YOSHIE, T; OGUCHI, S; TANAKA, E; KIYOSAWA, K; FURUTA, S


DETECTION OF CHRONIC HEPATITIS-C VIRUS-INFECTION BY 4 DIAGNOSTIC SYSTEMS - 1ST-GENERATION AND 2ND-GENERATION ENZYME-LINKED-IMMUNOSORBENT-ASSAY, 2ND-GENERATION RECOMBINANT IMMUNOBLOT ASSAY AND NESTED POLYMERASE CHAIN-REACTION ANALYSIS
HEPATOLOGY,16(2):300-305 1992
Author:NAKATSUJI, Y; MATSUMOTO, A; TANAKA, E; OGATA, H; KIYOSAWA, K


NEW HEPATOCELLULAR-CARCINOMA CELL-LINE SUHC-1 ESTABLISHED FROM A PATIENT WITH HEPATITIS-C VIRUS-RNA IN SERUM
JAPANESE JOURNAL OF CANCER RESEARCH,83(8):871-877 1992
Author:YOSHIZAWA, K; KIYOSAWA, K; USUDA, S; YABU, K; NAKATSUJI, Y; YAMADA, S; FURUTA, K; TANAKA, E; SODEYAMA, T; FURUTA, S; KANEKO, S; NAKANE, PK


PERSISTENCE OF VIREMIA IN PATIENTS WITH TYPE-C CHRONIC HEPATITIS DURING LONG-TERM FOLLOW-UP
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,27(9):812-816 1992
Author:YOUSUF, M; NAKANO, Y; TANAKA, E; SODEYAMA, T; KIYOSAWA, K


IMMUNOSUPPRESSIVE THERAPY PROMOTES THE REPLICATION OF HEPATITIS-C VIRUS, FOLLOWED BY EXACERBATION OF LIVER-DISEASE AFTER DOSAGE REDUCTION OR WITHDRAWAL
HEPATOLOGY,16(4):A215-A215 1992
Author:NAKATSUJI, Y; KIYOSAWA, K; FURIHATA, K; TANAKA, E; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; MAKUUCHI, M


PERFORMANCE OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY SYSTEM FOR ANTIBODIES TO HEPATITIS-C VIRUS WITH 2 NEW ANTIGENS (C11/C7)
CLINICAL CHEMISTRY,38(12):2434-2439 1992
Author:SAITO, M; HASEGAWA, A; KASHIWAKUMA, T; KOHARA, M; SUGI, M; MIKI, K; YAMAMOTO, T; MORI, H; OHTA, Y; TANAKA, E; KIYOSAWA, K; FURUTA, S; WAKASHIMA, M; TANAKA, S; HATTORI, N


CAROLIS-DISEASE IN 3 SIBLINGS
GASTROENTEROLOGIA JAPONICA,27(6):780-784 1992
Author:YOSHIZAWA, K; KIYOSAWA, K; YABU, K; USUDA, S; SHIMIZU,S; FUJIMORI, Y; MUKAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S


A HIGH PREVALENCE OF ANTIBODY TO THE HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN JAPAN
CANCER,67(2):429-433 1991
Author:NISHIOKA, K; WATANABE, J; FURUTA, S; TANAKA, E; IINO, S; SUZUKI, H; TSUJI, T; YANO, M; KUO, G; CHOO, QL; HOUGHTON, M; ODA, T


SIGNIFICANCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITH VIRAL-HEPATITIS - RELATIONSHIP BETWEEN ANTI-HCV ANTIBODY AND THE PROGNOSIS OF NON-A, NON-B POSTTRANSFUSION HEPATITIS
JOURNAL OF MEDICAL VIROLOGY,33(2):117-122 1991
Author:TANAKA, E; KIYOSAWA, K; SODEYAMA, T; NAKANO, Y; YOSHIZAWA, K; HAYATA, T; SHIMIZU, S; NAKATSUJI, Y; KOIKE, Y; FURUTA, S


INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS IN JAPAN
JOURNAL OF MEDICAL VIROLOGY,33(2):114-116 1991
Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E; SHIMIZU, S; FURUTA, S; MIYAZAKI, Y; AKAHANE, Y; SUZUKI, H


EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN SUBTYPES IN LIVER OF PATIENTS WITH HEPATOCELLULAR-CARCINOMA - COMPARISON OF SUBTYPES IN SERUM AND LIVER
LIVER,11(3):176-184 1991
Author:NAKATSUJI, Y; KIYOSAWA, K; TANAKA, E; SODEYAMA, T; HORIGOME, N; KAJIKAWA,S; NAITO, S; AKAHANE, Y


HEPATITIS-C IN HOSPITAL EMPLOYEES WITH NEEDLESTICK INJURIES
ANNALS OF INTERNAL MEDICINE,115(5):367-369 1991
Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, Y; FURUTA, S; NISHIOKA, K; PURCELL, RH; ALTER, HJ


COMPARATIVE-STUDY OF CLINICAL, HISTOLOGICAL, AND IMMUNOLOGICAL RESPONSES TO INTERFERON THERAPY IN TYPE-NON-A, TYPE-NON-B, AND TYPE-B CHRONIC HEPATITIS
AMERICAN JOURNAL OF GASTROENTEROLOGY,85(1):24-29 1990
Author:NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E


PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA
VOX SANGUINIS,59(2):86-88 1990
Author:WATANABE, J; MINEGISHI, K; MITSUMORI, T; ISHIFUJI, M; OGUCHI, T; UEDA, M; TOKUNAGA, E; TANAKA, E; KIYOSAWA, K; FURUTA, S; KATAYAMA, T; KUO, G; CHOO, QL; HOUGHTON, M; NISHIOKA, K


INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS
HEPATOLOGY,12(4):671-675 1990
Author:KIYOSAWA, K; SODEYAMA, T; TANAKA, E; GIBO, Y; YOSHIZAWA, K; NAKANO, Y; FURUTA, S; AKAHANE, Y; NISHIOKA, K; PURCELL, RH; ALTER, HJ


TRANSITION OF ANTIBODY TO HEPATITIS-C VIRUS FROM CHRONIC HEPATITIS TO HEPATOCELLULAR-CARCINOMA
JAPANESE JOURNAL OF CANCER RESEARCH,81(11):1089-1091 1990
Author:KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, K; USUDA, S; YOUSUF, M; FURUTA, S


Clinical impact of normal alanine aminotransferase on direct‐acting antiviral outcome in patients with chronic hepatitis C virus infection
JGH Open
Author:Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E

特許等知的財産
登録済特許
HBV-RNAを含むHBV粒子
B型肝炎ウイルスの薬物抵抗性を識別する方法
C型慢性肝炎の治療効果を事前に予測するためのキット
競合PCR法による核酸の簡易定量法